Skip to main
CNC

Centene (CNC) Stock Forecast & Price Target

Centene (CNC) Analyst Ratings

Based on 15 analyst ratings
Hold
Strong Buy 7%
Buy 20%
Hold 60%
Sell 7%
Strong Sell 7%

Bulls say

Centene demonstrated a solid financial position with a Medicaid Health Benefit Ratio (HBR) of 93.4%, reflecting a year-over-year improvement, and the company anticipates continued enhancements in rate structures which contribute to approximately 50% of annualized premium revenue. Additionally, Centene's Medicare membership reached 1.01 million, aligning with expectations, while the Pharmacy Drug Plan (PDP) membership of 7.97 million exceeded projections, indicating robust demand in its service offerings. The company's composite rate improvement forecast of approximately 5.5% and a sequential improvement in Medical Loss Ratio (MLR) highlight effective management strategies and a strong outlook for future performance.

Bears say

Centene's financial outlook appears negative due to an anticipated decline in the percentage of its portfolio in low-cost Silver positions, projected to decrease to 42% in 2026 from 55% in 2025, indicating potential revenue challenges. Additionally, the company faces a substantial expected earnings impact of around $2.4 billion pre-tax for FY25, attributed to lower-than-expected risk adjustment figures, which has the potential to further strain financial stability. Finally, the risks associated with deteriorating marketplace risk scores, persistent pressure on Medicaid margins, and uncertainties surrounding the Part D business contribute to an overall pessimistic view of Centene's future performance.

Centene (CNC) has been analyzed by 15 analysts, with a consensus rating of Hold. 7% of analysts recommend a Strong Buy, 20% recommend Buy, 60% suggest Holding, 7% advise Selling, and 7% predict a Strong Sell.

This aggregate rating is based on analysts' research of Centene and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Centene (CNC) Forecast

Analysts have given Centene (CNC) a Hold based on their latest research and market trends.

According to 15 analysts, Centene (CNC) has a Hold consensus rating as of Feb 19, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $41.40, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $41.40, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Centene (CNC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.